Interferon regulatory factor 9 promotes lung cancer progression via regulation of versican

Transcription factors can serve as links between tumor microenvironment signaling and oncogenesis. Interferon regulatory factor 9 (IRF9) is recruited and expressed upon interferon stimulation and is dependent on cofactors that exert in tumor-suppressing or oncogenic functions via the JAK-STAT pathwa...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Brunn, David (VerfasserIn) , Turkowski, Kati (VerfasserIn) , Günther, Stefan (VerfasserIn) , Weigert, Andreas (VerfasserIn) , Muley, Thomas (VerfasserIn) , Kriegsmann, Mark (VerfasserIn) , Winter, Hauke (VerfasserIn) , Dammann, Reinhard (VerfasserIn) , Stathopoulos, Georgios T. (VerfasserIn) , Thomas, Michael (VerfasserIn) , Guenther, Andreas (VerfasserIn) , Grimminger, Friedrich (VerfasserIn) , Pullamsetti, Soni S. (VerfasserIn) , Seeger, Werner (VerfasserIn) , Savai, Rajkumar (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 8 January 2021
In: Cancers
Year: 2021, Jahrgang: 13, Heft: 2
ISSN:2072-6694
DOI:10.3390/cancers13020208
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers13020208
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/13/2/208
Volltext
Verfasserangaben:David Brunn, Kati Turkowski, Stefan Günther, Andreas Weigert, Thomas Muley, Mark Kriegsmann, Hauke Winter, Reinhard H. Dammann, Georgios T. Stathopoulos, Michael Thomas, Andreas Guenther, Friedrich Grimminger, Soni S. Pullamsetti, Werner Seege, and Rajkumar Savai

MARC

LEADER 00000caa a2200000 c 4500
001 1750491869
003 DE-627
005 20241230003615.0
007 cr uuu---uuuuu
008 210304s2021 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers13020208  |2 doi 
035 |a (DE-627)1750491869 
035 |a (DE-599)KXP1750491869 
035 |a (OCoLC)1341398045 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Brunn, David  |d 1988-  |e VerfasserIn  |0 (DE-588)1228611068  |0 (DE-627)175049194X  |4 aut 
245 1 0 |a Interferon regulatory factor 9 promotes lung cancer progression via regulation of versican  |c David Brunn, Kati Turkowski, Stefan Günther, Andreas Weigert, Thomas Muley, Mark Kriegsmann, Hauke Winter, Reinhard H. Dammann, Georgios T. Stathopoulos, Michael Thomas, Andreas Guenther, Friedrich Grimminger, Soni S. Pullamsetti, Werner Seege, and Rajkumar Savai 
264 1 |c 8 January 2021 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.03.2021 
520 |a Transcription factors can serve as links between tumor microenvironment signaling and oncogenesis. Interferon regulatory factor 9 (IRF9) is recruited and expressed upon interferon stimulation and is dependent on cofactors that exert in tumor-suppressing or oncogenic functions via the JAK-STAT pathway. IRF9 is frequently overexpressed in human lung cancer and is associated with decreased patient survival; however, the underlying mechanisms remain to be elucidated. Here, we used stably transduced lung adenocarcinoma cell lines (A549 and A427) to overexpress or knockdown IRF9. Overexpression led to increased oncogenic behavior in vitro, including enhanced proliferation and migration, whereas knockdown reduced these effects. These findings were confirmed in vivo using lung tumor xenografts in nude mice, and effects on both tumor growth and tumor mass were observed. Using RNA sequencing, we identified versican (VCAN) as a novel downstream target of IRF9. Indeed, IRF9 and VCAN expression levels were found to be correlated. We showed for the first time that IRF9 binds at a newly identified response element in the promoter region of VCAN to regulate its transcription. Using an siRNA approach, VCAN was found to enable the oncogenic properties (proliferation and migration) of IRF9 transduced cells, perhaps with CDKN1A involvement. The targeted inhibition of IRF9 in lung cancer could therefore be used as a new treatment option without multimodal interference in microenvironment JAK-STAT signaling. 
650 4 |a adenocarcinoma 
650 4 |a interferon regulatory factor 9 (IRF9) 
650 4 |a lung cancer 
650 4 |a tumor microenvironment (TME) 
650 4 |a type I interferons (IFNs) 
650 4 |a versican (VCAN) 
700 1 |8 1\p  |a Turkowski, Kati  |e VerfasserIn  |0 (DE-588)1051040213  |0 (DE-627)785651535  |0 (DE-576)405666497  |4 aut 
700 1 |a Günther, Stefan  |e VerfasserIn  |4 aut 
700 1 |8 2\p  |a Weigert, Andreas  |d 1979-  |e VerfasserIn  |0 (DE-588)134215303  |0 (DE-627)564809314  |0 (DE-576)300381557  |4 aut 
700 1 |a Muley, Thomas  |e VerfasserIn  |0 (DE-588)1056885432  |0 (DE-627)794179169  |0 (DE-576)16759284X  |4 aut 
700 1 |a Kriegsmann, Mark  |d 1987-  |e VerfasserIn  |0 (DE-588)103740324X  |0 (DE-627)755668782  |0 (DE-576)39141870X  |4 aut 
700 1 |a Winter, Hauke  |e VerfasserIn  |0 (DE-588)1162076038  |0 (DE-627)1025509773  |0 (DE-576)176791531  |4 aut 
700 1 |8 3\p  |a Dammann, Reinhard  |d 1965-  |e VerfasserIn  |0 (DE-588)129658979  |0 (DE-627)476598583  |0 (DE-576)29777185X  |4 aut 
700 1 |a Stathopoulos, Georgios T.  |e VerfasserIn  |4 aut 
700 1 |a Thomas, Michael  |e VerfasserIn  |0 (DE-588)1054438781  |0 (DE-627)79152213X  |0 (DE-576)41027089X  |4 aut 
700 1 |a Guenther, Andreas  |e VerfasserIn  |4 aut 
700 1 |8 4\p  |a Grimminger, Friedrich  |e VerfasserIn  |0 (DE-588)112910629  |0 (DE-627)663356237  |0 (DE-576)346511135  |4 aut 
700 1 |a Pullamsetti, Soni S.  |e VerfasserIn  |4 aut 
700 1 |a Seeger, Werner  |e VerfasserIn  |4 aut 
700 1 |8 5\p  |a Savai, Rajkumar  |d 1976-  |e VerfasserIn  |0 (DE-588)131743678  |0 (DE-627)513596690  |0 (DE-576)298711621  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 13(2021,2) Artikel-Nummer 208, 19 Seiten  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Interferon regulatory factor 9 promotes lung cancer progression via regulation of versican 
773 1 8 |g volume:13  |g year:2021  |g number:2  |a Interferon regulatory factor 9 promotes lung cancer progression via regulation of versican 
856 4 0 |u https://doi.org/10.3390/cancers13020208  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/13/2/208  |x Verlag  |z lizenzpflichtig  |3 Volltext 
883 |8 1\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 2\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 3\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 4\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
883 |8 5\p  |a cgwrk  |d 20241001  |q DE-101  |u https://d-nb.info/provenance/plan#cgwrk 
951 |a AR 
992 |a 20210304 
993 |a Article 
994 |a 2021 
998 |g 1054438781  |a Thomas, Michael  |m 1054438781:Thomas, Michael  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PT1054438781  |e 950000PT1054438781  |e 950900PT1054438781  |e 50000PT1054438781  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 10 
998 |g 1162076038  |a Winter, Hauke  |m 1162076038:Winter, Hauke  |d 910000  |d 950000  |d 950900  |d 50000  |e 910000PW1162076038  |e 950000PW1162076038  |e 950900PW1162076038  |e 50000PW1162076038  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |k 0/50000/  |p 7 
998 |g 103740324X  |a Kriegsmann, Mark  |m 103740324X:Kriegsmann, Mark  |d 910000  |d 912000  |e 910000PK103740324X  |e 912000PK103740324X  |k 0/910000/  |k 1/910000/912000/  |p 6 
998 |g 1056885432  |a Muley, Thomas  |m 1056885432:Muley, Thomas  |d 910000  |d 950000  |d 950900  |e 910000PM1056885432  |e 950000PM1056885432  |e 950900PM1056885432  |k 0/910000/  |k 1/910000/950000/  |k 2/910000/950000/950900/  |p 5 
999 |a KXP-PPN1750491869  |e 3881868100 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"David","display":"Brunn, David","role":"aut","family":"Brunn"},{"family":"Turkowski","role":"aut","given":"Kati","display":"Turkowski, Kati"},{"role":"aut","display":"Günther, Stefan","given":"Stefan","family":"Günther"},{"role":"aut","given":"Andreas","display":"Weigert, Andreas","family":"Weigert"},{"role":"aut","display":"Muley, Thomas","given":"Thomas","family":"Muley"},{"family":"Kriegsmann","given":"Mark","display":"Kriegsmann, Mark","role":"aut"},{"given":"Hauke","display":"Winter, Hauke","role":"aut","family":"Winter"},{"family":"Dammann","role":"aut","given":"Reinhard","display":"Dammann, Reinhard"},{"given":"Georgios T.","display":"Stathopoulos, Georgios T.","role":"aut","family":"Stathopoulos"},{"family":"Thomas","given":"Michael","display":"Thomas, Michael","role":"aut"},{"given":"Andreas","display":"Guenther, Andreas","role":"aut","family":"Guenther"},{"family":"Grimminger","role":"aut","display":"Grimminger, Friedrich","given":"Friedrich"},{"family":"Pullamsetti","given":"Soni S.","display":"Pullamsetti, Soni S.","role":"aut"},{"display":"Seeger, Werner","given":"Werner","role":"aut","family":"Seeger"},{"family":"Savai","display":"Savai, Rajkumar","given":"Rajkumar","role":"aut"}],"title":[{"title":"Interferon regulatory factor 9 promotes lung cancer progression via regulation of versican","title_sort":"Interferon regulatory factor 9 promotes lung cancer progression via regulation of versican"}],"id":{"doi":["10.3390/cancers13020208"],"eki":["1750491869"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"name":{"displayForm":["David Brunn, Kati Turkowski, Stefan Günther, Andreas Weigert, Thomas Muley, Mark Kriegsmann, Hauke Winter, Reinhard H. Dammann, Georgios T. Stathopoulos, Michael Thomas, Andreas Guenther, Friedrich Grimminger, Soni S. Pullamsetti, Werner Seege, and Rajkumar Savai"]},"recId":"1750491869","relHost":[{"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"language":["eng"],"id":{"eki":["614095670"],"zdb":["2527080-1"],"issn":["2072-6694"]},"pubHistory":["1.2009 -"],"note":["Gesehen am 27.05.2020"],"origin":[{"publisherPlace":"Basel","publisher":"MDPI","dateIssuedDisp":"2009-","dateIssuedKey":"2009"}],"recId":"614095670","type":{"media":"Online-Ressource","bibl":"periodical"},"disp":"Interferon regulatory factor 9 promotes lung cancer progression via regulation of versicanCancers","physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Cancers","title":"Cancers"}],"part":{"volume":"13","issue":"2","year":"2021","text":"13(2021,2) Artikel-Nummer 208, 19 Seiten"}}],"origin":[{"dateIssuedDisp":"8 January 2021","dateIssuedKey":"2021"}],"note":["Gesehen am 04.03.2021"]} 
SRT |a BRUNNDAVIDINTERFERON8202